During the past decade, McLaren-Port Huron conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 5 clinical trials were completed, i.e. on average, 12.8% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 5 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "McLaren-Port Huron" #1 sponsor was "National Cancer Institute (NCI)" with 15 trials, followed by "NRG Oncology" with 10 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "SWOG Cancer Research Network" with 4 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "McLaren-Port Huron" #1 collaborator was "National Cancer Institute (NCI)" with 25 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "McLaren-Port Huron" are "Colon Adenocarcinoma" (3 trials), "Estrogen Receptor Negative" (3 trials), "HER2/Neu Negative" (3 trials), "Invasive Breast Carcinoma" (3 trials) and "Progesterone Receptor Negative" (3 trials). Many other conditions were trialed in "McLaren-Port Huron" in a lesser frequency.

Most popular intervention types in "McLaren-Port Huron" are "Drug" (27 trials), "Other" (25 trials), "Radiation" (20 trials), "Biological" (12 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (17 trials), "Questionnaire Administration" (12 trials), "Intensity-Modulated Radiation Therapy" (9 trials), "Fluorouracil" (8 trials) and "Laboratory Biomarker Analysis" (8 trials). Other intervention names were less common.

The vast majority of trials in "McLaren-Port Huron" are 33 trials for "All" genders, 5 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "McLaren-Port Huron". undefined are not yet recruiting, 12 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in McLaren-Port Huron, 3 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in McLaren-Port Huron, 1 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".